Education
About Us
Working with TipRanks
Follow Us
Galapagos (GLPG)
NASDAQ:GLPG
Earnings Data
Report Date
Jul 23, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.19Last Year’s EPS
0.08Same Quarter Last Year
Moderate Sell
Based on 5 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Apr 23, 2025
|% Change Since: 5.57%
|Next Earnings Date:Jul 23, 2025
Earnings Call Sentiment|Neutral
The earnings call reflects a strong commitment to expanding the clinical pipeline and enhancing manufacturing capabilities, supported by a robust financial position. However, significant restructuring costs and expected high cash burn post-separation highlight ongoing financial challenges.Company Guidance
During the Galapagos First Quarter 2025 Financial Results and Business Update conference call, several metrics were highlighted as part of the company's guidance. Galapagos reported total net revenues of EUR 75 million for the first quarter, with EUR 14 million stemming from supply revenues related to Jyseleca and EUR 61 million from collaboration revenues. The company incurred EUR 111 million in restructuring costs, which included severance, termination of collaborations, and impairment costs. Galapagos ended the first quarter with a cash balance of EUR 3.3 billion. Upon the planned separation of SpinCo, it is expected to have EUR 2.45 billion in cash, whereas Galapagos will retain approximately EUR 500 million. This financial outlook supports Galapagos’s strategy to accelerate its cell therapy pipeline and aims to sustain operations through 2028, with a normalized annual cash burn estimated between EUR 175 million and EUR 225 million, excluding restructuring. The company is also advancing its pipeline with the ATALANTA-1 study of GLPG5101 in hematological malignancies, aiming for pivotal development in 2026 and a potential first approval in 2028.First U.S. Patient Dosed in ATALANTA-1 Study
Galapagos dosed its first U.S. patient in the ATALANTA-1 study of GLPG5101, which is a novel CD19 CAR-T candidate. This marks a significant milestone in expanding their clinical pipeline in the U.S. and Europe.
Expansion of Decentralized Manufacturing Units (DMUs)
Galapagos expanded its decentralized manufacturing network in the U.S. and Europe, improving access to therapies and reducing logistical constraints. This is a major step in supporting pivotal studies and commercial readiness.
Strong Financial Position with EUR 3.3 Billion Cash Balance
Galapagos reported a cash balance of EUR 3.3 billion at the end of Q1 2025, providing significant runway to fund operations and accelerate the cell therapy pipeline.
Appointment of Henry Gosebruch as Founding CEO of SpinCo
The appointment of Henry Gosebruch as CEO of the new entity SpinCo is a major step in the planned separation, bringing deep expertise in M&A and business development.
---
GLPG Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
GLPG Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Apr 23, 2025 | $25.50 | $26.49 | +3.88% |
| Feb 12, 2025 | $24.97 | $25.49 | +2.08% |
| Oct 30, 2024 | $28.59 | $26.44 | -7.52% |
| Aug 01, 2024 | $26.89 | $25.52 | -5.09% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Galapagos (GLPG) report earnings?
Galapagos (GLPG) is schdueled to report earning on Jul 23, 2025, TBA Not Confirmed.
What is Galapagos (GLPG) earnings time?
Galapagos (GLPG) earnings time is at Jul 23, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is GLPG EPS forecast?
GLPG EPS forecast for the fiscal quarter 2025 (Q2) is -0.19.
---